A double-blind, randomised, placebo-controlled, cross-over study assessing the use of XEN-D0103 in patients with paroxysmal atrial fibrillation and implanted pacemakers allowing continuous beat-to-beat monitoring of drug efficacy

Opportunistic detection of atrial fibrillation in subjects aged 65 years or older in primare care: a randomised clinical trial of efficacy. DOFA-AP study protocol

(2013) LuisÁ Pérula-de-Torres et al.   BMC Family Practice

‘2012 focused update of the ESC Guidelines for the management of atrial fibrillation’ [Eur Heart J (2012); 33(21):2719–2747]

(2013) A. John Camm et al.   EUROPEAN HEART JOURNAL

A Randomized, Placebo-Controlled Study of Vernakalant (Oral) for the Prevention of Atrial Fibrillation Recurrence After Cardioversion

(2011) Christian Torp-Pedersen et al.   Circulation-Arrhythmia and Electrophysiology

New Pharmacological Agents for Arrhythmias

(2009) Pamela K. Mason et al.   Circulation-Arrhythmia and Electrophysiology

Indications for the use of diagnostic implantable and external ECG loop recorders

(2009) et al.   EUROPACE

Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation

(2008) T Christ et al.   BRITISH JOURNAL OF PHARMACOLOGY

New Drugs Targeting the Cardiac Ultra-Rapid Delayed-Rectifier Current (IKur): Rationale, Pharmacology and Evidence for Potential Therapeutic Value

(2008) John W Ford et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Atrial-Selective Approaches for the Treatment of Atrial Fibrillation

(2008) Joachim R. Ehrlich et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY